首页> 外文期刊>Nature >XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia
【24h】

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia

机译:XRCC1突变与PARP1过度活化和小脑性共济失调相关

获取原文
获取原文并翻译 | 示例
           

摘要

XRCC1 is a molecular scaffold protein that assembles multiprotein complexes involved in DNA single-strand break repair(1,2). Here we show that biallelic mutations in the human XRCC1 gene are associated with ocular motor apraxia, axonal neuropathy, and progressive cerebellar ataxia. Cells from a patient with mutations in XRCC1 exhibited not only reduced rates of single-strand break repair but also elevated levels of protein ADP-ribosylation. This latter phenotype is recapitulated in a related syndrome caused by mutations in the XRCC1 partner protein PNKP3-5 and implicates hyperactivation of poly(ADP-ribose) polymerase/s as a cause of cerebellar ataxia. Indeed, remarkably, genetic deletion of Parp1 rescued normal cerebellar ADP-ribose levels and reduced the loss of cerebellar neurons and ataxia in Xrcc1-defective mice, identifying a molecular mechanism by which endogenous single-strand breaks trigger neuropathology. Collectively, these data establish the importance of XRCC1 protein complexes for normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease.
机译:XRCC1是一种分子支架蛋白,可组装涉及DNA单链断裂修复的多蛋白复合物(1,2)。在这里,我们显示人XRCC1基因中的双等位基因突变与眼运动性失用症,轴突神经病和进行性小脑共济失调相关。来自XRCC1突变患者的细胞不仅显示出单链断裂修复率降低,而且蛋白ADP-核糖基化水平升高。在由XRCC1伴侣蛋白PNKP3-5突变引起的相关综合症中概括了后一种表型,并暗示聚(ADP-核糖)聚合酶过度活化是小脑共济失调的原因。确实,显着地是,Parp1的基因缺失挽救了正常的小脑ADP核糖水平,并减少了Xrcc1缺陷小鼠的小脑神经元损失和共济失调,从而确定了内源性单链断裂触发神经病理学的分子机制。总的来说,这些数据确立了XRCC1蛋白复合物对于正常神经功能的重要性,并确定PARP1是DNA链断裂修复缺陷性疾病的治疗靶标。

著录项

  • 来源
    《Nature》 |2017年第7635期|87-91|共5页
  • 作者单位

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England|Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    McGill Univ, Dept Human Genet, Montreal, PQ H3A OG4, Canada|Genome Quebec Innovat Ctr, Montreal, PQ H3A OG4, Canada;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

    Univ Sussex, Sch Life Sci, Neurosci, Brighton BN1 9QG, E Sussex, England;

    Univ Sussex, Sch Life Sci, Neurosci, Brighton BN1 9QG, E Sussex, England;

    Erasmus MC, Dept Clin Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands;

    St Jude Childrens Res Hosp, Memphis, TN 38105 USA;

    Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany;

    Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1L 8H1, Canada;

    Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada|Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada;

    Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号